3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year

One of these, Vertex Pharmaceuticals (NASDAQ: VRTX), which has a large and growing current drug business, is profitable. Plus, the drugmaker dominates its market. The combination of high earnings growth and a developing pipeline is creating a good opportunity for investors, and there are three reasons why the next year could be big for the company.